Lymphogranuloma venereum (LGV)—caused by Chlamydia trachomatis serovars L1, L2, or
L3—rarely occurs in the United States. The disease clinically manifests in three stages …

The purpose of the study was to evaluate the clinic prevalence and clinical characteristics of
patients with LGV since 2007 when active clinic surveillance started. We review all the …

Background Lymphogranuloma venereum (LGV) has reestablished itself as an endemic
sexually transmitted infection in the United Kingdom and elsewhere in Europe and North …

Since the end of 2003, an ongoing lymphogranuloma venereum (LGV) proctitis outbreak
has been reported in industrialised countries, first in The Netherlands, followed by …

Lymphogranuloma venereum (LGV) was an unusual disease in Europe until 2003, when
several outbreaks among men who have sex with men (MSM) emerged. Since 2015, LGV …

Background Lymphogranuloma venereum (LGV) is a sexual transmitted infection (STI),
currently endemic within the population of men who have sex with men (MSM) of Western …

Definitive diagnosis of lymphogranuloma venereum is impeded by difficulty in culturing the
causative agent and by serologic cross-reactivity between Chlamydia trachomatis L1, L2 …

(LGV) serovar L2b presenting initially with edema and persistent painful ulceration illustrate
that clinical manifestations of LGV in the current outbreak in men who have sex with men …

A patient with proctitis and inguinal buboes diagnosed with lymphogranuloma venereum
(LGV) was treated with doxycycline 21 days, azithromycin 20 days and moxifloxacin for a …

To determine prevalence of lymphogranuloma venereum among men who have sex with
men in Germany, we conducted a multicenter study during 2009–2010 and found high rates …